Efficacy and Safety of Sericin and Chitosan Cream for Preventing and Limiting the Progressive of Pressure Sore

Chulalongkorn University

Status: Unknown

Conditions: Pressure Ulcer

Treatments: Other: sericin and chitosan cream

Study type: Interventional

Funder types: Other

Identifiers

NCT04559165

Dh09066063

Details and patient eligibility

About

To evaluate efficacy and safety of sericin and chitosan cream for preventing and limiting the progressive of pressure sore in 20 patients

Enrollment: 20 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age more than 18 years old
• 2-digit Stirling Pressure Sore Severity Scale less than or equal to 2.4
• No chitosan, sericin, and dimethicone allergy
• Without skin diseases
• Without Autoimmune diseases
• Willingness to participate

Exclusion criteria

• Have uncontrolled diseases
• Have complication or adverse effects during the time of participation
• Cannot follow protocol
• Pregnancy or lactation
• Participate in other study

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

20 participants in 2 patient groups

sericin and chitosan cream

Experimental group

Description:

Apply sericin and chitosan cream on pressure ulcer 2 times/day for 21 days.

Treatment:

Other: sericin and chitosan cream

Cavilon cream

Active Comparator group

Description:

Apply cavilon cream on pressure ulcer 2 times/day for 21 days.

Treatment:

Other: sericin and chitosan cream